Request Demo
Last update 13 Dec 2025
An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)
Last update 13 Dec 2025
Overview
Basic Info
Drug Type TCR-T Cell therapy |
Synonyms NW-101C |
Target |
Action inhibitors |
Mechanism PRAME inhibitors(PRAME nuclear receptor transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)NCT07266298
A Phase I, Multicenter, Dose-escalation, Single-arm Study of PRAME Antigen-targeted TCR-T Cells(NW-101C) in the Treatment of Subjects With Advanced Solid Malignant Tumors.
100 Clinical Results associated with An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)
Login to view more data
100 Translational Medicine associated with An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)
Login to view more data
100 Patents (Medical) associated with An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)
Login to view more data
100 Deals associated with An autologous TCR-T product targeting a PRAME derived peptide(Neowise Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Solid Tumor | Phase 1 | China | 01 Dec 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 13 Nov 2025 | |
| Ovarian Cancer | Clinical | China | - | |
| Synovial Sarcoma | Clinical | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free